As shown in Fig. 5, the affordability of chemotherapy medicines for acute lymphoblastic leukaemia was least in north-west and south-west China, where 7.4 days’ and 6.7 days’ income, respectively, was required to afford a course of asparaginase induction therapy. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.